January 15, 2018 – C-Mer Eye Care Holdings Limited (“C-Mer Eye Care”, stock code: 03309.HK) was successfully listed on the Main Board of Hong Kong Stock Exchange. It issued globally a total of 197 million shares at HK$ 2.9 each and was oversubscribed by 1,569.3 times. Capturing net proceeds of HK$520 million, it broke the record of subscriptions by individual investors for IPOs over $50 million in Hong Kong. The issuer’s cornerstone investors included Mr. Pony Ma-- founder of Tencent Holdings Ltd., Mr. Yong Zhao, son of Ms. Lihua Chen -- the chairman of Fu Wah International Group Co., Ltd., Mr. Lee-yuen Ying—the head of Gunther Group Limited and Mr. Zhiwen Sheng -- Chairman of Hong Kong Lan Kwai Fong Capital Group.

C-Mer Eye Care was founded by the renowned ophthalmologist Dr. Dennis Shun Chiu Lam, a Fellow of the Royal College of Ophthalmologist and other international academies of ophthalmologists, who serves as Hong Kong deputy of the National People’s Congress of China.  C-Mer Eye Care has a network of two eye surgery centers and four satellite clinics in Hong Kong as well as two privately-owned C-MER hospitals in both Shenzhen and Beijing. The Shenzhen C-Mer Hospital in is the first domestic privately-owned hospital established under CEPA. The net proceeds from this public offering will be utilized to expand in the domestic market, by opening new or acquiring existing eye hospitals in the mainland.

As the sponsor’s Chinese legal counsel, the Jingtian & Gongcheng legal team served C-Mer Eye Care throughout the entire IPO process.